The revision of those standards resulted in the adoption of the amendments EN ISO 10993-23:2021/A1:2025 on additional in vitro reconstructed human epidermis models, EN ISO 10993-12:2021/A1:2025, EN ISO 10993-17:2023/A1:2025, EN IEC 60601-2-83:2020/A1:2025 and EN ISO 15223-1:2021/A1:2025 on addition of defined term for authorized representative and modified EC REP symbol to not be country or region specific (‘the amendments’).
Recital 4, Decision_act (EU) 2026/1231
In forcesince 11 Jun 2026